With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, pharmaceutical services and active ingredients, and proprietary products and other, which make up most of the company's revenue at about 80%, 15%, and 3%. Most of the company’s sales are based in the United States.
AMAT, FTV, BXP, CAH, MRO, DIS, MCD
Soo RomanoffEquity Analyst